Apoptosis, senescence, and cancer
Author(s)
Bibliographic Information
Apoptosis, senescence, and cancer
（Cancer drug discovery and development）
Humana Press, c2007
2nd ed.
Available at / 6 libraries
-
No Libraries matched.
- Remove all filters.
Note
Includes bibliographical references and index
2nd ed. by cover title
Description and Table of Contents
Description
This book provides insight into established practices and research into apoptosis and senescence. The volume thoroughly examines novel and emerging techniques and research in the fields of cell death pathways, senescence growth arrest, drugs and resistance, DNA damage response, and other topics that still hold mysteries for researchers. In total, this volume provides basic scientists and clinicians with a deeper and more complete understanding of the cellular responses of malignancies which may determine the effectiveness of treatment, both in the initial stages of the disease as well as in disease recurrence.
Table of Contents
Apoptosis, Senescence and Cancer
Section I: Apoptosis and Alternative Models of Cell Death
Chapter 1. The intrinsic pathway of apoptosis. Scott H. Kaufman
Chapter 2. The extrinsic pathway of apoptosis. M. Stacey Ricci and Wafik S. El-Deiry
Chapter 3. Evaluating the importance of apoptosis and other determinants of cell death and survival. Bradley G. Wouters and Roland K. Chiu
Chapter 4. Mitotic catastrophe. Fiorenza Ianzini and Michael A. Mackey
Chapter 5. Autophagy and autophagic cell death. Mojgan Djavaheri-Mergny, Joelle Botti and Patrice Codogno
Chapter 6. Regulation and function of detachment-induced cell death (anoikis) in cancer progression and metastasis. David J. McConkey and Victor Bondar
Section II. Telomeres and Telomerase, Senescence, Genomic Instability and Tumorigenesis
Chapter 7. Structure and function of the telomere. Jay E. Johnson and Dominique Broccoli
Chapter 8. Overview of Senescence. Ruben D. Ramirez
Chapter 9. Contributions of telomerase to tumorigenesis. Richard Possemato and William C. Hahn
Chapter 10. The role of telomeres in genomic instability. John P. Murnane
Section III. DNA Damage Response, Signaling Pathways and Tumorigenesis
Chapter 11. Overview of the DNA damage checkpoint -- ATM and ATR. Aude Dupre and Jean Gautier
Chapter 12. Interactions between myc and cyclin dependent kinase inhibitors in cancer. Kirsteen H. Maclean and John L. Cleveland
Chapter 13. Interplay between H2AX and 53BP1 pathways in DNA double strand break repair response. Fatouros Chronis and Emmy P. Rogakou
Chapter 14. DNA-dependent protein kinase in repair, apoptosis, telomere maintenance and chemotherapy. Lawrence F. Povirk
Section IV. Resistance and Sensitization
Chapter 15. Resistance/signaling pathways. Paul Dent
Chapter 16. Ceramide and multi-drug resistance. Myles C. Cabot
Chapter 17. Chemo and radio-sensitization through inhibition of PI3/Akt signaling. Debra L. Smith, Laura K. Nolden, Gordon B. Mills and Yiling Lu
Chapter 18. The advancement of epidermal growth factor receptor inhibitors in cancer therapy. Gregory W. Allen and Paul M. Harari
Section V. Established Cancer Therapies
Chapter 19. Antimetabolites. Janet A. Houghton
Chapter 20. Topoiseomerase I poisons and apoptotic topoisomerase I-DNA complexes. Olivier Sordet, Yves Pommier and Eric Solary
Chapter 21. Perturbations of cellular functions by topoisomerase II inhibitors: all roads lead to cell death? Annette K. Larsen and Andrzej Skladanowski
Chapter 22. The significance of poly-targeting in apoptosis induction by alkylating agents and platinum drugs. Jan M. Woynarowski and Barbara A. Woynarowska
Chapter 23. Contributions of apoptosis and senescence to cytotoxicity produced by microtubule stabilizing agents. Laura E. Klein and Susan B. Horwitz
Section VI. Recent and Developing Cancer Therapies
Chapter 24. Tyrosine kinase inhibitors. Michael Deininger
Chapter 25. Humanized antibodies. Morton Coleman and Richard Furman
Chapter 26. Role of apoptosis in anti-angiogenic cancer therapies. Jennifer A. Doll, Jennifer E. Hobbs and Gerald A. Soff
Chapter 27. Photodynamic therapy-induced apoptosis. Nancy L. Oleinick, Rachel L. Morris and Anna Lisa Nieminen
Chapter 28. Modulation of TRAIL signaling for cancer therapy. Simone Fulda and Klaus-Michael Debatin
by "Nielsen BookData"
